E88.3 – Tumor lysis syndrome
Coding Notes
Active
Billable, valid for HIPAA-covered transactions
Additional
code for adverse effect, if applicable, to identify drug (T45.1X5)
Applicable To
Tumor lysis syndrome (spontaneous)
Tumor lysis syndrome following antineoplastic drug chemotherapy
GEM Conversion to ICD-9 CM
Fs: 00000
–
Tumor lysis syndrome
MDC / MS-DRG Reference
Back Reference of Diagnostic Codes
Syndrome
See also Disease
tumor lysis NEC
(following antineoplastic chemotherapy) (spontaneous)
E88.3
Tumor lysis syndrome NEC
(following antineoplastic chemotherapy) (spontaneous)
E88.3
Sibling Codes
Parent Sibling Codes
View in Tabular
Code | Title |
---|---|
E00-E89 | Endocrine, nutritional and metabolic diseases (E00-E89) |
E70-E88 | Metabolic disorders (E70-E88) |
E88 | Other and unspecified metabolic disorders |
E88.3 |
Tumor lysis syndrome
Use Additional
code for adverse effect, if applicable, to identify drug (T45.1X5)
Applicable to
Tumor lysis syndrome (spontaneous)
Tumor lysis syndrome following antineoplastic drug chemotherapy
|